J. Burns, R. A. Ouvrier, E. M. Yiu and M. M. Ryan, “Extended Treatment of Childhood Charcot-Marie-Tooth Disease with High-Dose Ascorbic Acid,” Journal of the Peripheral Nervous System, Vol. 16, No. 3, 2011, pp. 272 274. doi:10.1111/j.1529-8027.2011.00348.x

has been cited by the following article:

• TITLE: Subarachnoid and Peripheral Nerve Block in a Patient with Charcot-Marie-Tooth Disease

  AUTHORS: Stinson T. Ritter, Ryan J. Jense, Joanna M. Davies

  KEYWORDS: Charcot-Marie-Tooth Disease; CMT; Regional Anesthesia; Neuraxial Anesthesia

  JOURNAL NAME: Open Journal of Anesthesiology, Vol.3 No.1, January 31, 2013

  ABSTRACT: Charcot-Marie-Tooth disease (CMT) is a hereditary peripheral neuropathy characterized by progressive distal muscle weakness and wasting. If conservative treatment fails, or is not appropriately initiated, deformity, immobility and chronic pain may result. In severe cases, surgical intervention may be required. With the exception of case reports and case series, limited safety and efficacy data exists regarding the use of neuraxial and regional anesthesia for patients with CMT. This paper describes an anesthetic case report of a patient with CMT, and also provides a review of general and regional anesthetic considerations for this cohort. The purpose of this report is to highlight the potential benefits of neuraxial and regional anesthesia in patients with neuromuscular disorders, especially in settings where intra- and post-operative resources may be limited.